Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,530.00p
   
  • Change Today:
    -24.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 2,234.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 11,530
  • Market Cap: 1,664.07m
  • RiskGrade: 128

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-21 Interim 281.20 24.40 42.40p 10.30p

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 459.10 40.70 69.40p 25.6 1.8 +14% 23.60p 1.3%
30-Jun-18 470.30 7.80 75.90p 34.7 3.9 +9% 26.00p 1.0%
30-Jun-19 488.50 9.90 73.20p 36.2 n/a -4% 27.70p 1.0%
30-Jun-20 551.40 46.30 77.30p 45.7 7.6 +6% 29.10p 0.8%
30-Jun-21 574.30 55.80 100.90p 49.2 1.6 +30% 32.00p 0.6%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-22 585.57 72.22 83.74p 30.5 n/a -17% 33.40p 1.3%
30-Jun-23 633.72 79.92 92.94p 27.5 2.5 +11% 36.31p 1.4%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 25.65 25.65 38.28 0.66

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,530.00p
Change Today -24.00p
% Change -0.94 %
52 Week High 6,070.00
52 Week Low 2,234.00
Volume 11,530
Shares Issued 65.77m
Market Cap 1,664.07m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.7% below the market average94.7% below the market average94.7% below the market average94.7% below the market average94.7% below the market average
92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average
Price Trend
80.16% below the market average80.16% below the market average80.16% below the market average80.16% below the market average80.16% below the market average
23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average23.81% below the sector average
Income
84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average84.33% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
48.05% above the market average48.05% above the market average48.05% above the market average48.05% above the market average48.05% above the market average
70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average70.00% above the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Mar-22 18-Nov-21
Paid 31-Mar-22 10-Dec-21
Amount 10.30p 21.70p

Trades for 04-Jul-2022

Time Volume / Share Price
15:45 1 @ 2,534.00p
15:43 37 @ 2,530.00p
15:43 3 @ 2,530.00p
15:39 17 @ 2,538.00p
15:36 18 @ 2,540.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page